Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-77c89778f8-sh8wx Total loading time: 0 Render date: 2024-07-22T13:15:37.873Z Has data issue: false hasContentIssue false

Ch. 13 - Combination of Approaches in Augmentation Fillers in Cosmetic Dermatology

Published online by Cambridge University Press:  26 February 2010

By
Susan H. Weinkle MD  and
Harriet Lin Hall ARNP
Edited by
Neil S. Sadick
Neil S. Sadick
Affiliation:
Cornell University, New York
Get access

Summary

INTRODUCTION

Dermal filling agents and botulinum neurotoxin are currently widely utilized for facial augmentation and global restoration of the aging face. For years, the conventional wisdom regarding dermal injectables for facial rejuvenation was “Botox for the upper face; Fillers for the lower face.” However, cosmetic dermatologists have advanced from the practice of treating single lines and wrinkles toward filling large facial areas to globally restoring natural facial contours (Ditre, 2008). Cosmetic dermatologists now have a better understanding of the facial aging process, and as new fillers become available, there is an increased recognition that when treating the aging face, the combination of soft tissue augmentation and botulinum toxin takes part in principal roles to fill, lift, tighten, and relax rhytids.

OVERVIEW OF INJECTABLE DERMAL FILLERS

Over the last four years, the US Food and Drug Administration (FDA) has approved many dermal filling agents. European countries and South America have had numerous dermal filling agents available for several years. Therefore, it can be quite difficult to decide what filler to use and where the filler should be injected. Injectable dermal fillers can be grouped according to their degree of degradability. In general, fillers may be classified into biodegradable and nonbiodegradable products. The degradable material may be further classified into xenografts (derived from another species such as bovine collagen or hyaluronic acid of bacterial or avian origin), autografts (from the same person, such as autologous fat), and synthetic products (PLLA and CaHA) (Jones, 2007, p. 106).

Type
Chapter
Information
Augmentation Fillers , pp. 117 - 128
Publisher: Cambridge University Press
Print publication year: 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Barnett, J. and Barnett, C. (2005). Treatment of acne scars with liquid silicone injections: 30 year perspective. Dermatologic Surgery, 21, 1542–1549.CrossRefGoogle Scholar
Busso, M. (2008). Soft tissue augmentation: nonsurgical approaches to treatment of the mid and lower facial regions. Dermatology Nursing, 20, 211–219.Google ScholarPubMed
Carruthers, J. and Carruthers, A. (2008). Fillers Working By Fibroplasias: Radiesse. In: Carruthers, J., Carruthers, A. (Eds.) Soft Tissue Augmentation. Saunders, Philadelphia, pp. 87–89.Google Scholar
Carruthers, J.D. and Carruthers, A. (2005). Facial sculpting and tissue augmentation. Dermatologic Surgery, 31, 1604–1612.CrossRefGoogle ScholarPubMed
Coleman, K.R. and Carruthers, J. (2006). Combination therapy with Botox and fillers: the new rejuvenation paradigm. Dermatologic Therapy, 19, 177–188.CrossRefGoogle ScholarPubMed
Ditre, C.M. (2008). Dermal fillers for facial rejuvenation and restoration: integrating new therapies into clinical practice. Cosmetic Dermatology, 21(Suppl. 2 S1), 11–14.Google Scholar
Jones, D. (2007). Dermal Fillers. In: Goldberg, D. (Ed.) Facial Rejuvenation. Springer, New York, pp. 106–123.Google Scholar
Klein, A.W. (2005). In search of the perfect lip: 2005. Dermatologic Surgery, 31, 1599–1603.CrossRefGoogle ScholarPubMed
Lemperle, G., Romano, J., and Busso, M. (2003). Soft tissue augmentation with Artecoll: 10 year history, indications, techniques, and complications. Dermatologic Surgery, 29, 573–587.Google ScholarPubMed
Matarasso, S.L. and Sadick, N.S. (2003). Soft tissue augmentation. In: Dermatology. Mosby, New York City, pp. 2439–2449.Google Scholar
Miller, T., Klein, A., and Lambros, V. (2001). Soft tissue augmentation. Journal of Aesthetic Surgery, 20, 309–314.CrossRefGoogle Scholar
Monheit, G. and Prather, C. (2007). Hyaluronic acid fillers for the male patient. Dermatologic Therapy, 20, 394–406.CrossRefGoogle ScholarPubMed
Monheit, G.D. (2008). Dermal fillers for facial rejuvenation and restoration: integrating new therapies into clinical practice. Cosmetic Dermatology, 21(Suppl. 2 S1), 7–10.Google Scholar
Narins, R., Michaels, J., and Cohen, J. (2008). Hylans and Soft Tissue Augmentation. In: Carruthers, J., Carruthers, A. (Eds.) Soft Tissue Augmentation. Saunders Elsevier, Philadelphia, pp. 31–50.Google Scholar
Rendon, M. (2007). Nonsurgical total facial restoration: combining therapies for optimal patient outcomes: a case study approach. Cosmetic Dermatology, 20(Suppl. 2 S1), 6–8.Google Scholar
Rotunda, A. and Narins, R. (2006). Poly-L-lactic acid: a new dimension in soft tissue augmentation. Dermatologic Therapy, 19, 151–158.CrossRefGoogle ScholarPubMed
Rzany, B. and Zielke, H. (2006). Overview of Injectable Fillers. In: Maio, M., Rzany, B. (Eds.) Injectable Fillers in Aesthetic Medicine: Springer, Berlin, pp. 1–9.CrossRefGoogle Scholar
Smith, K. (2007). New fillers for the new man. Dermatologic Therapy, 20, 388–393.CrossRefGoogle ScholarPubMed
Werschler, W.P. (2008). Dermal fillers for facial rejuvenation and restoration: integrating new therapies into clinical practice. Cosmetic Dermatology, 21(Suppl. 2 S1), 3–7.Google Scholar
Werschler, W.P. (2007). Nonsurgical total facial restoration: combining therapies for optimal patient outcomes: a case study approach. Cosmetic Dermatology, 20(Suppl. 2 S1), 9–13.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×